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 No Association between Serum Ferritin 
Levels  1 10   g/l and Hair Loss Activity in 
Women 
 Amadé Bregy    Ralph M. Trüeb 
 Department of Dermatology, University Hospital of Zurich,  Zurich , Switzerland 
the lower limits of normal based on reference sample 
groups. In women of childbearing age, using a cutoff of 
10–15   g/l yields a sensitivity of 75% and specificity of 
98%  [19] . A cutoff of 30   g/l yields a sensitivity of 92% 
and a specificity of 98%  [18] . The reference laboratory cit-
ed in this study uses 10   g/l as lower limit of normal for 
menstruating women, and 30   g/l for children, men and 
nonmenstruating women.
 Increased shedding of telogen hair results either from 
synchronous transition of hair follicles from the growing 
(anagen) to the resting (telogen) stage of the hair cycle, or 
from progressive shortening of duration of anagen  [20, 
21] . The former mechanism underlies TE, the latter FPHL. 
Different methods have been adapted for quantification 
of hair loss. Of these, the trichogram is the first technique 
standardized for this purpose, and has probably been the 
most widely used in dermatologic practice. Initially de-
veloped in 1957 by van Scott’s group, subsequently other 
authors modified and standardized the technique defin-
ing uniform and strict criteria for reliably assessing the 
different morphological hair root structures to ensure 
comparable results  [22, 23] . A telogen rate of  1 15% in 
scalp hair is considered pathologic in women. In TE, the 
telogen rate is elevated in all regions of the scalp, includ-
ing the occipital area; in FPHL, the telogen rate is elevat-
ed in the frontal and centroparietal scalp region and 
spares the occipital scalp.
 Hair loss is a common complaint in women and affects 
over 25% of women in developed countries  [1] . Female 
pattern hair loss (FPHL) and diffuse telogen effluvium 
(TE) account for the majority of cases  [2–7] . In both con-
ditions, low iron stores have been considered a possible 
contributing factor. Therefore, assessment of serum fer-
ritin levels is generally recommended as part of the rou-
tine investigation, and dermatologists commonly pre-
scribe iron supplementation in women under the as-
sumption that low iron stores may cause hair loss. 
Contradictory observational data have so far failed to 
support this practice, however. Although nonanemic 
iron deficiency as an etiologic factor for diffuse hair loss 
in women was first postulated by Hard in 1963  [8] , it is 
not until recently that the significance of iron stores as 
assessed by serum ferritin levels in women with hair loss 
has been systematically studied  [9] . Various observation-
al studies have evaluated the association between de-
creased ferritin levels and hair loss and resulted in oppos-
ing conclusions  [10–16] . The controversy starts with a de-
bate over what is the normal serum ferritin level for 
women  [17] , and is further complicated by the use of dif-
ferent reference ranges by different laboratories, based on 
individual interpretations of the literature on this subject. 
A cutoff point of 10–15   g/l is considered to yield a sen-
sitivity of 59% and a specificity of 99% for diagnosing 
iron deficiency  [18] and is used by many laboratories as 
Published online: February 29, 2008
 Ralph M. Trüeb, MD 
 Department of Dermatology, University Hospital of Zurich 
 Gloriastrasse 31 
 CH–8091 Zurich (Switzerland) 
 Tel. +41 44 255 30 79, Fax +41 44 255 44 31, E-Mail ralph.trueeb@usz.ch 
 © 2008 S. Karger AG, Basel
1018–8665/08/2171–0001$24.50/0 
 Accessible online at:
www.karger.com/drm 
 Bregy/Trüeb
 
Dermatology 2008;217:1–62
 The goal of this study was to determine a relationship 
between serum ferritin levels and hair loss activity, as de-
termined by trichogram, in otherwise healthy women 
with FPHL or TE.
 Patients and Methods 
 Between 2002 and 2005, 418 consecutive women who present-
ed at the Department of Dermatology, University Hospital of Zu-
rich hair clinic, for assessment of hair loss underwent biochemical 
screening, including serum ferritin, and trichogram.
 For the trichogram, all patients had at least fifty hairs plucked 
from two sampling sites on the frontal and occipital scalp, using 
a tightly closing epilation forceps. Uniformly, patients were in-
structed to leave the hair unwashed and untreated with any cos-
metics for five days prior to the plucking of the hair for the tricho-
gram. Immediately after epilation, the hair roots were embedded 
in Histokitt TM mounting medium which had previously been 
spread onto a glass slide for light microscopy. The hair roots were 
arranged neatly in a juxtaposition and covered with a coverslip. 
Quantification of the different hair roots on the basis of their 
morphological characteristics relating to the hair cycle was per-
formed by the same investigator.
 Biochemical investigations included thyroid function tests, C-
reactive protein, and serum ferritin levels in all patients, renal and 
liver function tests, and hormonal studies in selected cases, as in-
dicated. Patients with a history of disease, abnormal laboratory 
studies (except ferritin levels), or on drugs, including hormones, 
known to cause hair loss, were excluded from this study.
 Statistical Analysis 
 Prior to statistical analyses, patients were coded as having 
FPHL or TE. FPHL was diagnosed either clinically (FPHL Ludwig 
patterns I–III with or without pathologic trichogram) or on the 
basis of a pathologic trichogram (frontal telogen rate  1 15%, oc-
cipital telogen rate normal). TE was diagnosed on the basis of a 
pathologic trichogram (occipital telogen rate  1 15%). Patients were 
subdivided into 3 subclasses: A: serum ferritin  ^  10   g/l, B: be-
tween 10 and 30   g/l, C: ferritin  1 30   g/l. For all subjects, sub-
jects with FPHL, and subjects with TE and each group, the Pear-
son’s product-moment correlation coefficient was calculated to 
determine a possible correlation between serum ferritin levels 
and telogen rates.
 Results 
 After exclusion of patients with a history of disease, 
abnormal laboratory studies (except ferritin levels), or on 
drugs known to cause hair loss, 181 otherwise healthy 
women with FPHL and/or TE remained.
 The mean age of these 181 women was 42.39 years 
(range: 13–81;  fig. 1 ), and the mean ferritin level was 53.14 
  g/l (range: 2–304). The total number of women with 
FPHL was 159 (87.8%), with a mean age of 42.82 years 
(range: 13–81). The mean ferritin level in this group was 
54.95   g/l (range: 3–304). This group was further subdi-
vided into: women with clinical FPHL (Ludwig I–III) and 
normal trichogram, women with frontal telogen rate 
 1 15% with or without clinical FPHL (‘active’ FPHL), and 
women with clinical FPHL and occipital telogen rate 
 1 15% (combined FPHL and TE). The number of women 
with clinical FPHL and normal trichogram was 29 (16.0%) 
with a mean age of 38.72 years (range: 13–78) and a mean 
ferritin level of 47.62   g/l (range: 5–146). The number of 
women with ‘active’ FPHL was 17 (9.4%) with a mean age 
of 42.94 years (range: 27–81) and a mean ferritin level of 
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 Fig. 1. Histogram showing distribution of patients and their age. 
1
10
100
1,000
F
e
rr
it
in
(µ
g
/l
)
0 20 40 60 80 100
Age (years)
 Fig. 2. Diagram showing correlation between patients’ age and 
their serum ferritin values. 
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45.41   g/l (range: 9–156). The number of women with 
combined FPHL and TE was 113 (62.4%) with a mean age 
of 43.86 years (range: 13–75) and a mean serum level of 
58.26   g/l (range: 3–304). The total number of women 
with TE (with or without clinical FPHL) was 135 (75.6%) 
with a mean age of 43.10 years (range: 13–75). The mean 
ferritin level in this group was 55.30   g/l (range: 2–304). 
The number of women with exclusive TE was 22 (12.2%) 
with a mean age of 39.23 years (range: 13–60) and a mean 
ferritin level of 40.09   g/l (range: 2–209). The mean age 
and serum ferritin values for all the subjects, subjects 
with FPHL, with TE, and subgroups are summarized in 
 table 1 .
 There were 112 (61.9%) women with a serum ferritin 
level  1 30   g/l, 55 (30.4%) between 10 and 30   g/l, and 14 
(7.7%) ferritin  ^  10   g/l. While there was a significant 
correlation (p  ! 0.001) between age of women and serum 
ferritin levels ( fig. 2 ), with younger (menstruating) wom-
en having lower ferritin levels, no correlation was found 
between ferritin levels  1 10   g/l and telogen rates, wheth-
er in total subjects, patients with FPHL, or patients with 
TE ( table 2 ;  fig. 3 ).
 Discussion 
 Iron deficiency represents the most common nutri-
tional deficiency with a prevalence of 12–16% in adoles-
cent girls and women of childbearing age (16–49 years of 
age) and 6–9% in women 50 years of age and older in the 
USA  [24] . The most common causes of iron deficiency in 
premenopausal women are menstrual blood loss, preg-
nancy and lactation, in postmenopausal women de-
creased absorption and gastrointestinal loss. Risk factors 
for iron deficiency include heavy menstrual bleeding 
( 6 80 ml per month), use of an intrauterine device, his-
tory of iron deficiency anemia, and insufficient iron in-
take.
 Total body iron is distributed among storage iron, 
transport iron, and functional iron. Storage iron is the 
body’s iron reserves that are tissue bound and measured 
by serum ferritin concentration; transport iron is trans-
Table 1. Mean age and ferritin values with 95% confidence intervals for all patients and subgroups
Age, years Ferritin, g/l
mean 95% CI median range mean 95% CI median range
All subjects (n = 181) 42.39 40.18–44.60 40 13–81 53.14 46.60–59.68 40 2–304
Total FPHL (n = 159) 42.82 40.43–45.22 40 13–81 54.95 47.96–61.93 41 3–304
Total TE (n = 135) 43.10 40.62–45.59 41 13–75 55.30 47.24–63.36 40 2–304
Subgroups
FPHL with normal TG (n = 29) 38.72 32.38–45.07 35 13–78 47.62 35.37–59.87 40 5–146
‘Active’ FPHL (n = 17) 42.94 35.98–49.90 41 27–81 45.41 27.44–63.39 37 9–156
FPHL without TE (n = 46) 40.28 35.54–45.02 38 13–81 46.80 36.73–56.88 39 5–156
FPHL with TE (n = 113) 43.86 41.10–46.62 42 13–75 58.26 49.37–67.15 46 3–304
Exclusive TE (n = 22) 39.23 33.76–44.69 39 13–60 40.09 21.95–58.23 30 2–209
Table 2. Correlation of serum ferritin levels and telogen rates by 
ferritin ranges
Ferritin range Frontal
telogen
rate, %
Occipital
telogen
rate, %
Mean
ferritin
value, g/l
Corre-
lation
(p < 0.05)
A (≤10 g/l)
All (n = 14) 21.93 21.08 6.64 n.s.
FPHL (n = 10) 21.96 19.70 7.30 n.s.
TE (n = 12) 21.40 22.55 6.58 n.s.
B (>10 to ≤30 g/l)
All (n = 55) 20.05 22.17 22.16 n.s.
FPHL (n = 47) 19.49 19.68 22.44 n.s.
TE (n = 38) 23.01 28.50 22.23 n.s.
C (>30 g/l)
All (n = 112) 20.14 24.66 74.17 n.s.
FPHL (n = 102) 19.59 23.32 74.59 n.s.
TE (n = 85) 22.21 29.81 76.96 n.s.
Total
All (n = 181) 20.25 23.63 53.14 n.s.
FPHL (n = 159) 19.71 22.02 54.95 n.s.
TE (n = 135) 22.36 28.79 55.30 n.s.
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ported to the tissues and measured by transferrin con-
centration and saturation, and functional iron consists 
of iron that is bound to hemoglobin, myoglobin and di-
verse enzymes. It is measured by hemoglobin concen-
tration.
 Iron deficiency is viewed as a continuum ranging from 
iron depletion to iron deficiency anemia. In the former, 
body iron stores are reduced, but functional and trans-
port iron remain normal, leaving little reserves if the 
body requires more iron, in the latter, storage, transport, 
and functional iron are severely decreased and can lead 
to impaired function of multiple organ sites. The symp-
toms of iron deficiency include fatigue and decreased ex-
ercise tolerance, signs of severe anemia include skin and 
conjunctival pallor, tachycardia, and low blood pressure, 
dermatologic findings include hair loss (basically TE), 
cheilosis, and koilonychia. It must be noted however that 
some patients with iron deficiency and even anemia may 
remain completely asymptomatic.
 Several studies have evaluated the relationship be-
tween iron deficiency and hair loss. Almost all of these 
studies have focused exclusively on women, and some 
suggest that iron deficiency even in the absence of iron 
deficiency anemia may cause hair loss  [10, 11, 13, 14, 16] , 
though others have challenged this view  [12, 15] . Never-
theless, it is common practice for dermatologists to pre-
scribe iron supplementation in women under the as-
sumption that low iron stores may cause hair loss, al-
though this practice is not evidence based per se.
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 Fig. 3. Diagram showing ferritin values and corresponding telo-
gen rates of the frontal and occipital scalp of all patients (n = 181; 
 a ), subjects with FPHL (n = 159;  b ) and subjects with TE (n = 135; 
 c ) in a linear scale. Vertical line A represents the lower reference 
limit of normal with 75% sensitivity and 98% specificity for diag-
nosing iron deficiency in women of childbearing age. Vertical line 
C represents the cutoff point with sensitivity of 92% and specific-
ity of 98% for diagnosing iron deficiency. Horizontal line X rep-
resents the cutoff point for pathologic telogen rate ( 1 15%). 
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 We evaluated the relationship between serum ferritin 
levels and hair loss activity, as determined by trichogram, 
in otherwise healthy women with FPHL and/or TE. Of 
418 women, 181 women who did not have any other fac-
tor responsible for TE, except for the variations of ferritin 
levels in question, were included in the study. Of the 181 
women diagnosed with FPHL and/or TE on the basis of 
clinical FPHL and/or a pathologic trichogram, a total of 
159 women suffered from FPHL, diagnosed either clini-
cally on the basis of Ludwig pattern hair loss I–III or a 
frontal telogen rate  1 15% in the absence of clinical FPHL, 
and 135 women suffered from TE, diagnosed on the basis 
of an occipital telogen rate  1 15%. Of these, 113 women 
suffered from a combination of FPHL and TE, diagnosed 
on the basis of Ludwig pattern hair loss I–III and an oc-
cipital telogen rate  1 15%. With reference to serum ferri-
tin levels, patients were subdivided into 3 subclasses: A, 
serum ferritin  ^  10   g/l (lower reference limit of normal 
with a sensitivity of 75% and a specificity of 98% for di-
agnosing iron deficiency in women of childbearing age); 
B, ferritin between 10 and 30   g/l; C, ferritin  1 30   g/l 
(lower reference limit of normal for children, men and 
nonmenstruating women with a sensitivity of 92% and a 
specificity of 98% for diagnosing iron deficiency). 112 
(61.9%) women were found to have a serum ferritin  1 30 
  g/l, 55 (30.4%) between 10 and 30   g/l, and 14 (7.7%) 
 ^  10   g/l. For each of the subclasses A–C and total sub-
jects, the Pearson’s product-moment correlation coeffi-
cient was calculated to determine a possible correlation 
between serum ferritin levels and telogen rates in all sub-
jects, patients with FPHL, and patients with TE ( fig. 3 ). 
While there was a significant correlation between age of 
women and ferritin levels, with younger (menstruating) 
women having lower ferritin levels ( fig. 2 ), no correlation 
was found between ferritin levels  1 10   g/l and telogen 
rates, whether in the groups B and C, or in total subjects. 
The number of patients in group A (serum ferritin  ^  10 
  g/l) was too small (n = 14) to draw any significant con-
clusions. Moreover, there were no significant differences 
in mean ferritin levels between women with clinical 
FPHL and normal trichogram (47.62   g/l), women with 
‘active’ FPHL (45.41   g/l), and women with combined 
FPHL and TE (58.26   g/l), while women with exclusive 
TE had a mean serum ferritin level of 40.09   g/l ( ta-
ble 1 ).
 We conclude that the role of tissue iron status in fe-
male hair loss has probably been overestimated since we 
found that a majority (61.9%) of women with hair loss due 
to FPHL, TE, or a combination of both have serum fer-
ritin levels above the cutoff point with 92% sensitivity 
and 98% specificity for diagnosing iron deficiency ( 1 30 
  g/l). In previous studies, Sinclair  [15]  also found that 
only 12/194 (6.2%) of women with alopecia had serum 
ferritin levels  ^  20   g/l, and Aydingoz et al. [12] found 
no significant difference in the prevalence of depleted 
iron stores found in total subjects with diffuse or female 
pattern alopecia versus controls (32.5 vs. 45.6%). More 
importantly, we found no association between hair loss 
activity assessed with the trichogram technique and se-
rum ferritin levels  1 10   g/l either in all subjects, patients 
with FPHL or patients with TE. A ferritin concentration 
of 10–15   g/l is generally considered to yield a sensitivity 
of 59% and a specificity of 99% for diagnosing iron defi-
ciency  [18] . In women of childbearing age, it yields a sen-
sitivity of 75% and a specificity of 98%  [19] , and is there-
fore cited as the lower limit of normal for menstruating 
women also by the reference laboratory of this study. Of 
the most recent authors claiming an association of de-
creased serum ferritin with alopecia in women, the levels 
were all within the stipulated ranges of normal. Kantor et 
al. [16] found in their androgenetic alopecia (or FPHL) 
and TE groups mean serum ferritin concentrations of 
37.3 and 50.1   g/l, respectively, versus 59.5   g/l in con-
trols. In patients with FPHL or TE who were  ^  40 years 
of age, mean serum ferritin concentrations were 15.0 and 
23.8   g/l, respectively, versus 62.3   g/l in controls. The 
values for patients with FPHL or TE are in accordance 
with our finding of a significant correlation between the 
age of women (with hair loss) and serum ferritin levels, 
with younger (menstruating) women having the lower 
ferritin levels ( fig. 2 ).
 The data presented herein show no correlation be-
tween hair loss activity and serum ferritin levels  1 10
  g/l in otherwise healthy women with FPHL, TE, or a 
combination of both. Therefore, it remains debatable 
whether therapeutic iron supplementation in these wom-
en is useful. Nevertheless, the final proof, if iron is ben-
eficial in these patients or not, will depend on the results 
of iron supplementation therapy performed in a double-
blind controlled manner in otherwise healthy women 
with hair loss due to FPHL or TE and serum ferritin lev-
els  1 10   g/l.
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